Scorpio X Ramps Ahead of Schedule, Driving Broad Upward Revisions to ALAB Results, Guidance and Price Target
AI summary card
Scorpio X Ramps Ahead of Schedule, Driving Broad Upward Revisions to ALAB Results, Guidance and Price Target
Q2 revenue grew 104% year over year, and the midpoint of Q3 revenue guidance implies about 40% sequential growth; JPMorgan is positive on Scorpio X and multiple interconnect product lines sustaining high growth, reiterating Overweight and raising the price target to $465.
- Q2 revenue reached $392 million, up 104% year over year and 27% quarter over quarter, above market expectations of $360 million.
- Q3 revenue guidance is $540 million to $560 million, with the midpoint implying about 40% sequential growth, significantly above the roughly 15% implied by the market before the earnings release.
- Scorpio is expected to become the company's largest revenue product family in Q3, one quarter earlier than expected, mainly driven by mass production of Scorpio X in the AWS Trainium 3 XPU project.
- 2026 and 2027 adjusted EPS forecasts were raised by 28.1% and 52.3%, respectively, to $3.90 and $6.15.
- The price target was raised from $280 to $465, implying about 28.6% potential upside versus the current price of $361.67.
Report interpretation
Overview
Astera Labs' Q2 results significantly exceeded market expectations, with Scorpio, Aries and Taurus all benefiting from demand for artificial intelligence infrastructure. Scorpio X has begun production shipments and is accelerating mass production with the AWS Trainium 3 XPU project, prompting management to issue Q3 guidance far stronger than expected. JPMorgan accordingly raised its earnings forecasts for 2026 to 2028 substantially, and believes new Scorpio X customers, PCIe Gen 6 and Gen 7 upgrades, Taurus bandwidth evolution, and the ramp of Leo/CXL controllers will jointly support growth in 2027.
Core views
The core view is that the company's growth drivers have expanded from a single product to multiple high-speed interconnect product lines. Scorpio X is ramping faster than previously expected, with more than 10 customer projects underway; Aries benefits from PCIe Gen 6 penetration and early Gen 7 opportunities; Taurus will expand alongside 800G, 1.6T and 3.2T deployments; Leo/CXL has secured a new design win with a U.S. hyperscale customer and is expected to achieve volume shipments in 2027. With high revenue growth and operating leverage, the company is expected to maintain a long-term operating margin of around 40%, but the current valuation already reflects high growth expectations.
Analysis framework
The report first compares Q2 revenue, EPS and margins with consensus expectations, then assesses the Scorpio X mass-production ramp based on Q3 management guidance; it then raises multi-year financial forecasts by incorporating customer projects, technology generations and mass-production timetables across product lines, and finally determines the price target using a peer PEG relative valuation method.
Methodology notes
Peer comparison using price-to-earnings ratios adjusted for earnings growth
The $465 price target is based on roughly 1x peer PEG, corresponding to about 60x the 2028 adjusted EPS forecast of $7.78.
Forecast revenue and profit based on product mass production, customer adoption and technology upgrade cadence
The forecast increases mainly reflect stronger Q3 guidance, faster Scorpio X mass production, continued growth in Aries and Taurus, and increased confidence in 2027 opportunities for Leo/CXL, custom chips and optical interconnect.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- ALAB.USCore covered company
- Strengths
- Holds a leading position in high-speed interconnect for artificial intelligence servers, with a top market share in PCIe retimers; Scorpio X mass production is accelerating, Aries, Taurus and Leo/CXL form a diversified growth portfolio, and the company has strong operating leverage.
- Weaknesses
- Valuation is at a relatively high level, growth depends on hyperscale customers' platform deployments and timely ramp of new products, and R&D investment requirements are high.
- Comparison
- Q2 revenue and EPS were both above consensus expectations, and the midpoint of Q3 revenue guidance implies about 40% sequential growth, clearly stronger than the market's prior expectation of about 15%.
- Risks
- Slowing demand for artificial intelligence infrastructure, delays in mass production of new products, intensified competition, slower-than-expected customer adoption of new technologies, and higher-than-expected R&D expenses.
Key data
- Q2 revenue$392 millionUp 104% year over year and 27% quarter over quarter, above market expectations of $360 million.
- Q2 adjusted EPS$0.80Above market expectations of $0.69.
- Q2 non-GAAP gross margin73.7%Above market expectations of about 73.0%.
- Q2 non-GAAP operating margin39.1%Above market expectations of about 36.8%.
- Q3 revenue guidance$540 million to $560 millionMidpoint of $550 million, implying about 40% sequential growth.
- Q3 non-GAAP operating margin guidanceAbout 43%Driven by revenue growth and operating leverage.
- Q3 non-GAAP EPS guidance$1.16 to $1.21Above prior market expectations.
- 2026 adjusted EPS forecast$3.90Prior estimate $3.04, raised by 28.1%.
- 2027 adjusted EPS forecast$6.15Prior estimate $4.04, raised by 52.3%.
- Price target$465Raised from $280; potential upside versus the current price of $361.67 is about 28.6%.
Impact & implications
Results and guidance show that demand for high-speed interconnect products in artificial intelligence accelerated computing platforms remains strong. Scorpio X becoming the largest product family ahead of schedule improves near-term revenue visibility, while Aries, Taurus and Leo/CXL enhance the breadth of growth in 2027. For investors, substantial upward revisions to earnings forecasts and the resonance of multiple product cycles support a positive rating; however, the target valuation of about 60x expected 2028 EPS is relatively high, and the share price will remain highly sensitive to changes in demand, mass-production timing and competition.
Risks
- Growth in artificial intelligence infrastructure demand may be lower than forecast.
- Mass production of new products such as Scorpio X and Leo/CXL or customer platform deployments may be delayed.
- Intensified competition may limit revenue growth and pricing power.
- Customer adoption of PCIe, CXL and next-generation networking technologies may be slower than expected.
- Higher-than-expected R&D spending may pressure earnings growth and operating leverage.
- The current valuation is relatively high; if growth or margins fall short of expectations, the risk of valuation contraction is substantial.
What to watch
- Mass-production progress and revenue contribution of Scorpio X in the AWS Trainium 3 XPU project.
- Timing of new customers moving into mass production among the more than 10 Scorpio X customer projects.
- Whether Scorpio can become the company's largest revenue product family in Q3 as scheduled.
- Aries PCIe Gen 6 penetration and early PCIe Gen 7 adoption progress.
- Taurus shipments, attach rates and average selling price changes in 800G, 1.6T and 3.2T platforms.
- 2027 volume shipment progress for Leo/CXL at two U.S. hyperscale customers.
- Whether the Q3 gross margin of about 72% and operating margin of about 43% can be achieved.
- Commercialization progress of custom interconnect chips and NPO/CPO optical interconnect opportunities.